Human Genome Epidemiology Literature Finder
Records 1 - 28 (of 28 Records) |
Query Trace: Breast Neoplasms and FGFR4[original query] |
---|
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer research 2002 Feb 62 (3): 840-7. Bange Johannes, Prechtl Dieter, Cheburkin Yuri, Specht Katja, Harbeck Nadia, Schmitt Manfred, Knyazeva Tatjana, Müller Susanne, Gärtner Silvia, Sures Irmi, Wang Hongyang, Imyanitov Evgeny, Häring Hans-Ulrich, Knayzev Pjotr, Iacobelli Stefano, Höfler Heinz, Ullrich Ax |
G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. British journal of cancer 2004 1 90 (1): 189-93. Jézéquel P, Campion L, Joalland M-P, Millour M, Dravet F, Classe J-M, Delecroix V, Deporte R, Fumoleau P, Ricolleau |
FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Oncology reports 2005 Aug 14 (2): 415-9. Spinola Monica, Leoni Vera Piera, Tanuma Jun-Ichi, Pettinicchio Angela, Frattini Milo, Signoroni Stefano, Agresti Roberto, Giovanazzi Riccardo, Pilotti Silvana, Bertario Lucio, Ravagnani Fernando, Dragani Tommaso |
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Aug 24 (23): 3747-55. Thussbas Christoph, Nahrig Jorg, Streit Sylvia, Bange Johannes, Kriner Monika, Kates Ronald, Ulm Kurt, Kiechle Marion, Hoefler Heinz, Ullrich Axel, Harbeck Nad |
The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma. Experimental and molecular pathology 2007 Feb 82 (1): 53-7. da Costa Andrade Valéria Cristina, Parise Orlando, Hors Cora Pereira, de Melo Martins Poliana Cristina, Silva Alexandre Pacheco, Garicochea Bernar |
Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. BMC cancer 2009 9 (1): 172. Nan Hongmei, Qureshi Abrar A, Hunter David J, Han Jia |
FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010 Aug 21 (8): 1636-42. Marmé F, Werft W, Benner A, Burwinkel B, Sinn P, Sohn C, Lichter P, Hahn M, Schneeweiss |
Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development. Oncology research 2009 18 (2-3): 65-71. Naidu R, Har Y C, Taib N |
A single nucleotide change in the mouse genome accelerates breast cancer progression. Cancer research 2010 1 70 (2): 802-12. Seitzer Nina, Mayr Thomas, Streit Sylvia, Ullrich Ax |
HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women. Molecular and cellular biochemistry 2011 Nov 357 (1-2): 247-53. Batschauer Anna P, Cruz Nathalia G, Oliveira Vanessa C, Coelho Fernanda F, Santos Izabela R, Alves Michelle T, Fernandes Ana P, Carvalho Maria G, Gomes Karina |
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer. International journal of cancer. Journal international du cancer 2012 Aug 131 (4): E586-91. Marmé Frederik, Hielscher Thomas, Hug Sarah, Bondong Sandra, Zeillinger Robert, Castillo-Tong Dan Cacsire, Sehouli Jalid, Braicu Ioana, Vergote Ignace, Isabella Cadron, Mahner Sven, Ferschke Irmgard, Rom Joachim, Sohn Christof, Schneeweiss Andreas, Altevogt Pet |
FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx. PloS one 2012 7 (11): e50747. Dutra Roberta Lelis, de Carvalho Marcos Brasilino, Dos Santos Marcelo, Mercante Ana Maria da Cunha, Gazito Diana, de Cicco Rafael, Group Gencapo, Tajara Eloiza Helena, Louro Iúri Drumond, da Silva Adriana Madeira Álvar |
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Feb . Vulsteke C, Lambrechts D, Dieudonné A, Hatse S, Brouwers B, van Brussel T, Neven P, Belmans A, Schöffski P, Paridaens R, Wildiers H |
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British journal of cancer 2014 Feb 110 (4): 1088-100. Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno L T, Alonso M R, Dennis J, Wang Q, Bolla M K, Meyer K B, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Lindblom A, Margolin S, Swerdlow A, Ashworth A, Orr N, Jones M, Matsuo K, Ito H, Iwata H, Kondo N, , , Hartman M, Hui M, Lim W Y, Iau P T -C, Sawyer E, Tomlinson I, Kerin M, Miller N, Kang D, Choi J -Y, Park S K, Noh D -Y, Hopper J L, Schmidt D F, Makalic E, Southey M C, Teo S H, Yip C H, Sivanandan K, Tay W -T, Brauch H, Brüning T, Hamann U, , Dunning A M, Shah M, Andrulis I L, Knight J A, Glendon G, Tchatchou S, Schmidt M K, Broeks A, Rosenberg E H, van't Veer L J, Fasching P A, Renner S P, Ekici A B, Beckmann M W, Shen C -Y, Hsiung C -N, Yu J -C, Hou M -F, Blot W, Cai Q, Wu A H, Tseng C -C, Van Den Berg D, Stram D O, Cox A, Brock I W, Reed M W R, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Zheng W, Deming-Halverson S, Shrubsole M J, Long J, Shu X -O, Lu W, Gao Y -T, Zhang B, Radice P, Peterlongo P, Manoukian S, Mariette F, Sangrajrang S, McKay J, Couch F J, Toland A E, , Yannoukakos D, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Marme F, Burwinkel B, Guénel P, Truong T, Sanchez M, Mulot C, Bojesen S E, Nordestgaard B G, Flyer H, Brenner H, Dieffenbach A K, Arndt V, Stegmaier C, Mannermaa A, Kataja V, Kosma V -M, Hartikainen J M, Lambrechts D, Yesilyurt B T, Floris G, Leunen K, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X, Olson J E, Vachon C, Purrington K, Giles G G, Severi G, Baglietto L, Haiman C A, Henderson B E, Schumacher F, Marchand L Le, Simard J, Dumont M, Goldberg M S, Labréche F, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Devilee P, Tollenaar R A E M, Seynaeve C, García-Closas M, Chanock S J, Lissowska J, Figueroa J D, Czene K, Eriksson M, Humphreys K, Darabi H, Hooning M J, Kriege M, Collée J M, Tilanus-Linthorst M, Li J, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Nevanlinna H, Muranen T A, Aittomäki K, Blomqvist C, Bogdanova N, Dörk T, Hall P, Chenevix-Trench G, Easton D F, Pharroah P D P, Arias-Perez J I, Zamora P, Benítez J, Milne R |
Re-evaluating the FGFR4 (G388R) germline mutation in different cancers in Pakistani population. Journal of experimental therapeutics & oncology 2013 10 (3): 215-7. Mansoor Qaisar, Fayyaz Sundas, Farooqi Ammad Ahmad, Bhatti Shahzad, Ismail Muhamm |
Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia. Pharmacogenomics 2015 Jul 16 (11): 1-10. Charehbili A, Groot S de, der Straaten T van, Swen J J, Pijl H, Gelderblom H, de Velde Cjh van, Nortier Jwr, Guchelaar H J, Kroep J |
Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province. Oncotarget 2015 Sep . Jiang Yongdong, Sun Shanshan, Wei Wei, Ren Yanlv, Liu Jing, Pang |
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel. OncoTargets and therapy 2016 9 5073-80. Kus Tulay, Aktas Gokmen, Kalender Mehmet Emin, Demiryurek Abdullah Tuncay, Ulasli Mustafa, Oztuzcu Serdar, Sevinc Alper, Kul Seval, Camci Celaletd |
Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases. JAMA oncology 2016 Dec . Priedigkeit Nolan, Hartmaier Ryan J, Chen Yijing, Vareslija Damir, Basudan Ahmed, Watters Rebecca J, Thomas Roby, Leone Jose P, Lucas Peter C, Bhargava Rohit, Hamilton Ronald L, Chmielecki Juliann, Puhalla Shannon L, Davidson Nancy E, Oesterreich Steffi, Brufsky Adam M, Young Leonie, Lee Adrian |
Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer. Molecular carcinogenesis 2018 4 57 (8): 988-996. Wei Wei, You Zilong, Sun Shanshan, Wang Yuhang, Zhang Xianyu, Pang Da, Jiang Yongdo |
Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients. BMC cancer 2018 Oct 18 (1): 1038. Chen Lu, Qi Huijie, Zhang Liudi, Li Haixia, Shao Jie, Chen Haifei, Zhong Mingkang, Shi Xiaojin, Ye Ting, Li Qun |
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. Journal of hematology & oncology 2020 2 13 (1): 13. Coussy F, El Botty R, Lavigne M, Gu C, Fuhrmann L, Briaux A, de Koning L, Dahmani A, Montaudon E, Morisset L, Huguet L, Sourd L, Painsec P, Chateau-Joubert S, Larcher T, Vacher S, Melaabi S, Salomon A Vincent, Marangoni E, Bieche |
Novel mutations in breast cancer patients from southwestern Colombia. Genetics and molecular biology 2020 11 43 (4): e20190359. Solarte Melissa, Cortes-Urrea Carolina, Franco Nelson Rivera, Barreto Guillermo, Moreno Pedro |
A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients. Annals of translational medicine 2020 11 8 (20): 1290. Sun Yi, Li Gao, Zhu Wei, He Qiuyan, Liu Yongchang, Chen Xianshan, Liu Juan, Lin Jing, Han-Zhang Han, Yang Zheng, Lizaso Analyn, Xiang Jianxing, Mao Xinru, Liu Hao, Gao Ya |
Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer. Frontiers in oncology 2021 3 11 588136. Tian Chonglin, Liu Sujing, Wang Yongsheng, Song Xianra |
Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences. Breast cancer research : BCR 2021 1 23 (1): 1. Priedigkeit Nolan, Ding Kai, Horne William, Kolls Jay K, Du Tian, Lucas Peter C, Blohmer Jens-Uwe, Denkert Carsten, Machleidt Anna, Ingold-Heppner Barbara, Oesterreich Steffi, Lee Adrian |
Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer. Scientific reports 2021 Jan 11 (1): 1373. Peng Tao, Sun Yangyang, Lv Zhiwei, Zhang Ze, Su Quanxin, Wu Hao, Zhang Wei, Yuan Wei, Zuo Li, Shi Li, Zhang Li-Feng, Zhou Xiaoli, Mi Yuanyu |
Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer. Nature communications 2023 8 14 (1): 5112. Lei-Jie Dai, Ding Ma, Yu-Zheng Xu, Ming Li, Yu-Wei Li, Yi Xiao, Xi Jin, Song-Yang Wu, Ya-Xin Zhao, Han Wang, Wen-Tao Yang, Yi-Zhou Jiang, Zhi-Ming Sh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: